Literature DB >> 9578179

Endocrine and adrenergic pharmacological intervention in diseases of the prostate.

A Rane1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9578179      PMCID: PMC1873965          DOI: 10.1046/j.1365-2125.1998.t01-1-00688.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  48 in total

1.  A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.

Authors:  C J Tyrrell; J E Altwein; F Klippel; E Varenhorst; G Lunglmayr; F Boccardo; I M Holdaway; J M Haefliger; J P Jordaan
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

2.  I. The Results of Double Castration in Hypertrophy of the Prostate.

Authors:  J W White
Journal:  Ann Surg       Date:  1895-07       Impact factor: 12.969

Review 3.  Prostatic growth: new insights into hormonal regulation.

Authors:  J D McConnell
Journal:  Br J Urol       Date:  1995-07

Review 4.  Molecular and cellular biology of the prostate: is it clinically relevant?

Authors:  F K Habib; E S Grant
Journal:  Br J Urol       Date:  1996-10

Review 5.  Classification of alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; B Kenny; D A Schwinn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

6.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Authors:  R K Ross; L Bernstein; R A Lobo; H Shimizu; F Z Stanczyk; M C Pike; B E Henderson
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

7.  Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2.

Authors:  T Jørgensen; K J Tveter; L H Jørgensen
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

8.  Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids.

Authors:  R Stege; A Eriksson; P Henriksson; K Carlström
Journal:  Int J Androl       Date:  1987-08

Review 9.  Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.

Authors:  R A Young; R N Brogden
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 10.  Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists.

Authors:  S Yamada; C Tanaka; R Kimura; K Kawabe
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

View more
  1 in total

1.  A 6-month large-scale study into the safety of tamsulosin.

Authors:  M C Michel; H U Bressel; M Goepel; H Rübben
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.